According to GlobalData’s medical device pipeline database, eight Carotid Artery Bare Metal Stents devices are in various stages of development globally. GlobalData’s report provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, five are in active development, while the remaining four are in an inactive stage of development. All devices are in the late stages of development.
A Carotid Artery Bare Metal Stent is a metal-mesh tube that is implanted to increase the flow of blood in a narrowed carotid artery. One unit refers to one carotid artery bare metal stent.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Carotid Artery Bare Metal Stents pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Carotid Artery Bare Metal Stents devices. Overall, most of these Carotid Artery Bare Metal Stents pipeline devices are being developed by private entities.
Key players involved in the active development of Carotid Artery Bare Metal Stents include InspireMD, MicroPort Scientific, Nesstent, Palmaz Scientific, Shanghai HeartCare Medical Technology, Contego Medical and CR Bard.
For a complete picture of the developmental pipeline for Carotid Artery Bare Metal Stents devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.